Category Archives: Vascular Biology

Dr Roger Preston: I think that keeping a balance between work and life outside work is a challenge. We associate Covid-19 with lung problems, but you recently got funding from Science Foundation Ireland to look at it further afield in the body, can you explain? In the early days of Covid-19 there was a lot of attention on the lungs, because this is often the immediate site of damage in the body Continue reading →

Findings included a reduction in fever, an increase in white blood cells and a sharp decrease of c-reactive protein (CRP) levels. Continue reading →

Read Time: Treating severe COVID-19 patients with the anticancer drug bevacizumab may reduce mortality and speed up recovery, according to a small clinical study in Italy and China that was led by researchers at Karolinska Institutet in Sweden between February and April 2020. On average, blood oxygen levels, body temperature and inflammatory markers significantly improved in patients treated with a single dose of bevacizumab in addition to standard care. The research is published inNature Communications. Continue reading →

Method, based on analysis of EEG patterns of abnormal brain electrical activity, can rapidly diagnose and monitor brain vascular pathology such as Alzheimer's disease, stroke, head injuries as well as psychiatric conditions Technology paves the way to optimize personal treatments given to patients and to help assess the efficacy of new drug under development BEER-SHEVA, Israel, Feb. 9, 2021 /PRNewswire/ -- Researchers at Ben-Gurion University of the Negev (BGU) have developed a new method for rapidly diagnosing brain blood vessel pathology that may lead to neurodegenerative diseases, such as Alzheimer's disease, as well as other neurological and psychiatric conditions, including epilepsy, traumatic brain injury and stroke. The novel method is based on analysis of EEG patterns using proprietary algorithms and was invented by Dr. Continue reading →

Introduction Osteoarthritis (OA) is the most common joint disease. It has an increasing prevalence in the more and more aging population1 and presents a large burden for the healthcare systems since it remains so far untreatable. A huge bulk of novel literature arises daily in OA research presenting a demanding challenge for OA researchers to notice the emerging innovations Continue reading →

MoMa Therapeutics Asit Parikh was named president and chief executive officer of Cambridge, Mass.-based MOMA Therapeutics. Parikh will assume the role April 5 Continue reading →

Regenerative medicine is a branch of translational research in tissue engineering and molecular biology which deals with the process of replacing, engineering or regenerating human cells, tissues or organs to restore or establish normal function. Continue reading →

Peripheral artery disease (PAD) and diabetes mellitus (DM) are leading causes of nontraumatic lower limb amputation in the United States. Microvascular disease (MVD) was found to be associated with lower limb amputation, independently of PAD and DM status, a risk increased in a synergistic manner in individuals with comorbid PAD, according to a review published in Arteriosclerosis, Thrombosis, and Vascular Biology. This observation has potential implications for the treatment of PAD, MVD and concomitant disease, as well strategies to prevent amputations. Continue reading →

INTRODUCTION Chronic kidney disease (CKD) has become a major public health problem worldwide. The prevalence of CKD is high, ranging from 10 to 13% in the adult population (1, 2). A considerable number of patients with CKD will eventually progress to end-stage renal disease, a devastating condition that needs renal replacement therapy. Continue reading →

Leading experts in central nervous system (CNS) clinical development and translational sciences to advise companys advancement of therapeutic pipeline candidates CAMBRIDGE, Mass., Jan. 25, 2021 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc Continue reading →